Adaptive Biotechnologies ...

7.67
-0.03 (-0.39%)
At close: Jan 28, 2025, 2:13 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 170.28M 185.31M 154.34M 98.38M 85.07M 55.66M 38.45M
Cost of Revenue 75.55M 57.91M 49.30M 22.53M 22.27M 19.67M 15.68M
Gross Profit 94.72M 127.40M 105.04M 75.85M 62.80M 35.99M 22.77M
Operating Income -227.03M -200.19M -208.97M -152.82M -78.39M -49.76M -44.48M
Interest Income 15.53M 4.06M 1.67M 6.59M 9.79M 3.31M 1.64M
Pretax Income -225.30M -200.37M -207.30M -146.23M -68.61M -46.45M -42.83M
Net Income -225.25M -142.46M -205.61M -139.64M -58.82M -46.45M -42.83M
Selling & General & Admin 172.51M 184.13M 169.97M 110.89M 68.78M 44.90M 32.71M
Research & Development 122.12M 141.76M 142.34M 116.07M 70.70M 39.16M 32.00M
Other Expenses 27.13M 1.70M 1.70M 1.70M 1.70M 1.70M 1.69M
Operating Expenses 321.76M 327.58M 314.01M 228.67M 141.19M 85.75M 66.40M
Interest Expense 13.80M 4.24M n/a n/a n/a n/a n/a
Selling & Marketing Expenses 88.58M 95.60M 95.47M 61.36M 38.45M 24.49M 16.77M
Cost & Expenses 397.31M 385.49M 363.31M 251.20M 163.46M 105.42M 82.08M
Income Tax n/a -57.90M -1.69M -6.59M -9.79M 3.31M -804.00K
Shares Outstanding (Basic) 144.38M 142.52M 140.35M 131.22M 69.17M 105.43M 105.43M
Shares Outstanding (Diluted) 144.38M 142.52M 140.35M 131.22M 69.17M 105.43M 105.43M
EPS (Basic) -1.56 -1 -1.46 -1.06 -0.85 -0.44 -0.41
EPS (Diluted) -1.56 -1 -1.46 -1.06 -0.85 -0.44 -0.41
EBITDA -189.27M -167.98M -193.34M -144.34M -70.60M -43.76M -37.84M
Depreciation & Amortization 22.23M 28.15M 20.98M 11.74M 7.79M 6.00M 5.80M

Create Price Alert on ADPT

Your price alert will notify you when the stock price is above 7.67.

Add to Watchlist